carrying ethyl acrylate, displaying
hazardous materials information including a diamond-shaped
U.S. DOT placard showing a
UN number The
International Agency for Research on Cancer stated, "Overall evaluation, ethyl acrylate is possibly carcinogenic to humans (Group 2B)." The
United States Environmental Protection Agency (EPA) states, "Human studies on occupational exposure to ethyl acrylate... have suggested a relationship between exposure to the chemical(s) and colorectal cancer, but the evidence is conflicting and inconclusive. In a study by the National Toxicology Program (NTP), increased incidence of
squamous cell papillomas and carcinomas of the forestomach were observed in rats and mice exposed via gavage (experimentally placing the chemical in the stomach). However, the NTP recently determined that these data were not relevant to human carcinogenicity since humans do not have a forestomach, and removed ethyl acrylate from its list of carcinogens." However, ethyl acrylate also increased the incidence of thyroid follicular cell adenoma in male mice, and thyroid follicular cell adenoma or carcinoma (combined) in male rats exposed through inhalation. It is possibly carcinogenic and it is toxic in large doses, with an
LD50 (rats, oral) of 1020 mg/kg. As of October 2018, the
FDA withdrew authorization for its use as a synthetic flavoring substance in food. One favorable safety aspect is that ethyl acrylate has good warning properties; the
odor threshold is much lower than the concentration required to create an atmosphere immediately dangerous to life and health. Reports of the exact levels vary somewhat, but, for example, the EPA reports an odor threshold of 0.0012 parts per million (ppm), which is almost 7000 times the odor threshold. However, as a possible carcinogen, NIOSH maintains "that there is no safe level of exposure to a carcinogen. Reduction of worker exposure to chemical carcinogens as much as possible through elimination or substitution and engineering controls is the primary way to prevent occupational cancer." ==References==